Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 3/20 | 0.40 |
| ▸ | PRKDC | P78527 | 8/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.32 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | MTOR | P42345 | 1/20 | 0.32 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.32 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17307479 | 0.96 | ALOX5 (0.42) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307464 | 0.95 | ALOX5 (0.45) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307477 | 0.92 | ALOX5 (0.40) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307478 | 0.89 | ALOX5 (0.42) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307482 | 0.88 | ALOX5 (0.33) | ALOX5PRKDCPGR | |
| SCHEMBL17307460 | 0.87 | ALOX5 (0.45) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307476 | 0.87 | ALOX5 (0.35) | ALOX5PRKDCPGR | |
| SCHEMBL17126001 | 0.87 | ALOX5 (0.38) | ALOX5PRKDCPGRPIK3CDPIK3CB | |
| SCHEMBL17307484 | 0.87 | ALOX5 (0.47) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL17307473 | 0.87 | ALOX5 (0.47) | ALOX5PRKDCPGRPIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-9653690-B2 | Organic compound, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2017-05-16 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150349270-A1 | ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE | OCIAD1, OXER1, OR10J3 | ALOX5 798/4885PRKDC 2184/4885PGR 4450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.